| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 04/09/2003 | EP1300398A1 Propane-1,3-dione derivatives |
| 04/09/2003 | EP1300396A1 1,2-dihydropyridine compounds, process for preparation of the same and use thereof |
| 04/09/2003 | EP1300145A1 Therapeutic or preventive medicines for mood disorders or anxiety disorders |
| 04/09/2003 | EP1299398A1 Methods and kits for the detection of arginine compounds |
| 04/09/2003 | EP1299393A2 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof |
| 04/09/2003 | EP1299388A1 Variolin derivatives as anti-cancer agents |
| 04/09/2003 | EP1299387A1 Heterocycle carboxamides as antiviral agents |
| 04/09/2003 | EP1299386A1 Pyrroloquinolones as antiviral agents |
| 04/09/2003 | EP1299382A1 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives |
| 04/09/2003 | EP1299378A1 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 04/09/2003 | EP1299362A1 Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof |
| 04/09/2003 | EP1299360A2 Heterocycle carboxamides as antiviral agents |
| 04/09/2003 | EP1299094A2 Selective androgen receptor modulators and methods for their identification, design and use |
| 04/09/2003 | EP0946165B1 Integrin antagonists |
| 04/09/2003 | EP0902684B1 Hexahydro-pyrido(4,3-b)indole derivatives as antipsychotic drugs |
| 04/09/2003 | EP0873123B1 Inhibitors of protein isoprenyl transferases |
| 04/09/2003 | EP0792257B1 Material for dichroic light polarizers |
| 04/09/2003 | EP0771197B1 Use of heterocyclic compounds as dopamines-d 3- ligands |
| 04/09/2003 | CN1409713A Fused heterotricyclic compound, process for preparing compounds and drugs containing the same |
| 04/09/2003 | CN1409711A Fused naphthalene dinitrogen compound useful as HIV reverse transcriptase inhibitors |
| 04/09/2003 | CN1105154C Process for preparation of quinacridone solid solutions |
| 04/09/2003 | CN1105113C Fungicidal pyrimidinones |
| 04/08/2003 | USRE38073 Biosynthesis; using dehydration agent |
| 04/08/2003 | US6545161 Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them |
| 04/08/2003 | US6545149 Synthesis and crystallization of piperazine ring-containing compounds |
| 04/08/2003 | US6545017 Urea substituted imidazopyridines |
| 04/08/2003 | US6545016 Inducing cytokine biosynthesis; treating a viral and neoplastic diseases |
| 04/08/2003 | US6545015 Useful in therapy of bacterial infections, fungal infections |
| 04/08/2003 | US6545014 Glaucoma; adjusting concentration of nitric oxide; hypotensive, antispasmodic, antiischemic, cardiotonic agents; bronchodilators; urogentital disorders; agonists, antagonists for endothelin receptors |
| 04/08/2003 | US6545013 2,7-naphthyridine derivatives |
| 04/08/2003 | US6545011 PARP (poly(adenosine 5'-diphospho-ribose) polymerase) inhibitors |
| 04/08/2003 | US6545005 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 04/08/2003 | US6544987 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 04/08/2003 | US6544978 Treating Alzheimer's disease both prophylactically and therapeutically |
| 04/08/2003 | CA2254152C New metalloprotease inhibitors, their preparation process and the pharmaceutical compositions which use them |
| 04/08/2003 | CA2112165C Bicyclic amine derivatives |
| 04/03/2003 | WO2003027114A1 Preparation and use of 1,5,6,7-tetrahydropyrrolo[3,2-c]pyridine derivatives for treatment of obesity |
| 04/03/2003 | WO2003027113A1 1,6-naphthyridine derivatives as antidiabetics |
| 04/03/2003 | WO2003027112A1 1, 8-naphthyridine derivatives as antidiabetics |
| 04/03/2003 | WO2003027111A1 Chemical compounds |
| 04/03/2003 | WO2003027110A2 Process for preparing 2-(4-pyridyl) amino-6-dialkyloxyphenyl-pyrido [2,3-d]pyrimidin-7-ones |
| 04/03/2003 | WO2003027108A1 Heterocyclic derivatives and their use as hypoglycaemic and hypolipidemic agents |
| 04/03/2003 | WO2003027103A1 Synthesis of key azole-antifungal intermediates |
| 04/03/2003 | WO2003027081A2 NOVEL LIGANDS FOR THE HisB10 Zn2+ SITES OF THE R-STATE INSULIN HEXAMER |
| 04/03/2003 | WO2003026652A1 Lactam-containing compounds and derivatives thereof as factor xa inhibitors |
| 04/03/2003 | WO2003026587A2 Compounds useful for treating hepatitus c virus |
| 04/03/2003 | WO2002102313A3 Pyrimidine inhibitors of phosphodiesterase (pde) 7 |
| 04/03/2003 | WO2002089729A3 Fused heterocyclic compounds |
| 04/03/2003 | WO2002086078A3 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents |
| 04/03/2003 | WO2002012200A9 Preparation of risperidone |
| 04/03/2003 | US20030065187 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 04/03/2003 | US20030065179 Diabetic therapy |
| 04/03/2003 | US20030065173 Therapy for drug abuse |
| 04/03/2003 | US20030065146 Compound for use in the treatment of rheumatoid arthritis, osteoarthritis, inflammatory bowel disease and sepsis |
| 04/03/2003 | US20030065005 Heterocyclic ether substituted imidazoquinolines |
| 04/03/2003 | US20030064998 Aqueous suspensions of submicron 9-hydroxyrisperidone fatty acid esters |
| 04/03/2003 | US20030064993 Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders |
| 04/03/2003 | US20030064992 N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors |
| 04/03/2003 | US20030064982 Pyrazole compounds useful as protein kinase inhibitors |
| 04/03/2003 | US20030064981 Anticancer agents; antidiabetic agents; Alzheimer's disease |
| 04/03/2003 | US20030064978 Analgesics; antiinflammatory agents |
| 04/03/2003 | US20030064962 Protease inhibitor; viricide |
| 04/03/2003 | US20030064374 Detecting neuronal stress in humans; obtain sample, measure phosphodiesterase concentration, evaluate for neuronal stress |
| 04/03/2003 | US20030064315 N,N'-ditrifluoromethanesulphonyloxy-4,4'-(phenylene-1,3-dioxy) dinaphthalene-1,8:1',8'-tetracarboxylic imide increases the degree of polymerization; for passivation layer, buffer coating, or dielectric film in printed circuits |
| 04/03/2003 | CA2726702A1 Lactam-containing compounds and derivatives thereof as factor xa inhibitors |
| 04/03/2003 | CA2463039A1 1,6-naphthyridine derivatives as antidiabetics |
| 04/03/2003 | CA2461142A1 Preparation and use of 1,5,6,7-tetrahydropyrrolo[3,2-c]pyridine derivatives for treatment of obesity |
| 04/03/2003 | CA2461132A1 1, 8-naphthyridine derivatives as antidiabetics |
| 04/03/2003 | CA2460541A1 Novel ligands for the hisb10 zn2+ sites of the r-state insulin hexamer |
| 04/03/2003 | CA2446904A1 Delivery of drug esters through an inhalation route |
| 04/03/2003 | CA2424057A1 Process for preparing 2-(4-pyridyl) amino-6-dialkyloxyphenyl-pyrido [2,3-d]pyrimidin-7-ones |
| 04/02/2003 | WO2002030891A1 Aliphatic nitrogenous five-membered ring compounds |
| 04/02/2003 | EP1298348A1 Bush, group of bush, suspension cross-member, vehicle, method for mounting a bush and method for mounting a group of bushes |
| 04/02/2003 | EP1298127A1 Amino acid-n-carboxy anhydrides hvaing substituent at nitrogen |
| 04/02/2003 | EP1298125A1 Substituted benzimidazole compounds and their use for the treatment of cancer |
| 04/02/2003 | EP1297108A2 Cell lines and cell-based assays for identification of androgen receptor modulators |
| 04/02/2003 | EP1296982A1 1-(heteroaryl-phenyl)-condensed pyrazol derivatives as factor xa inhibitors |
| 04/02/2003 | EP1296981A2 Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors |
| 04/02/2003 | EP1296975A1 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors |
| 04/02/2003 | EP1296972A1 Arylmethylamine derivatives for use as tryptase inhibitors |
| 04/02/2003 | EP1296958A1 Iminopyrimidine nmda nr2b receptor antagonists |
| 04/02/2003 | EP1296949A2 Piperidine amides as modulators of chemokine receptor activity |
| 04/02/2003 | EP1296686A2 Praziquantel compositions for treating diseases due to sarcocystis, neospora, toxoplasma and isospora |
| 04/02/2003 | EP1296681A2 Use of microsomal triglyceride transfer protein (mtp) inhibitors for reducing the number of postprandial triglyceride-rich lipoprotein particles (pptrl) |
| 04/02/2003 | EP1228069B1 Bicyclic and tricyclic heteroaromatic compounds |
| 04/02/2003 | EP1226143B1 Imidazopyridine derivatives used as phosphodiesterase vii inhibitors |
| 04/02/2003 | EP1192155B1 New bispidine compounds useful in the treatment of cardiac arrhythmias |
| 04/02/2003 | EP0985671B1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT |
| 04/02/2003 | EP0951467B1 SUBSTITUTED NITROGEN CONTAINING HETEROCYCLES AS INHIBITORS OF p38 PROTEIN KINASE |
| 04/02/2003 | EP0934320B1 Naphthyridine derivatives |
| 04/02/2003 | EP0770081B1 Heterocycle-condensed morphinoid derivatives |
| 04/02/2003 | CN1407984A 1,8-naphthyridin-2 (1H)-one derivatives |
| 04/02/2003 | CN1407983A Tert-butyl-(7-methyl-imidazo [1,2-A] pyridine-3-yl)-amine derivatives |
| 04/02/2003 | CN1407970A Urea compounds having muscarinic receptor antagonist activity |
| 04/02/2003 | CN1104430C Angiogenesis inhibiting pyridazinamines |
| 04/02/2003 | CN1104418C Benzoheterocyclic derivatives |
| 04/01/2003 | US6541669 Multibinding amine compounds which are beta 2 adrenergic receptor agonists useful in treatment and prevention of respiratory diseases such as asthma, bronchitis |
| 04/01/2003 | US6541634 Process for preparing growth hormone secretagogues |
| 04/01/2003 | US6541505 Inhibiting the activity of Factor Xa; treating a disease state associated with a physiologically detrimental excess amount of thrombin. |
| 04/01/2003 | US6541503 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |